Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in management of COVID-19: A review
Soraya Mouffak, Qamar Shubbar, Ekram Saleh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112107-112107
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 115
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Arwa A. Al-Qahtani, Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 1, pp. 13-13
Open Access | Times Cited: 89
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 80
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
Linda Nab, Edward P K Parker, Colm Andrews, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 5, pp. e364-e377
Open Access | Times Cited: 63
COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants
Ana Hernández‐Aceituno, Abigail García-Hernández, Eneko Larumbe‐Zabala
Infectious Diseases Now (2023) Vol. 53, Iss. 5, pp. 104688-104688
Open Access | Times Cited: 56
Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies
Erica Balboni, Federico Zagnoli, Tommaso Filippini, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 71, pp. 126956-126956
Open Access | Times Cited: 59
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
Joyeuse Ukwishaka, Yves Ndayishimiye, Esmeralda Destine, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 28
Omicron variant evolution on vaccines and monoclonal antibodies
Michela Sabbatucci, Antonio Vitiello, Salvatore Clemente, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1779-1788
Open Access | Times Cited: 25
A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies
Changxing Li, Sobia Noreen, Lixue Zhang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112550-112550
Open Access | Times Cited: 41
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Russel J. Reıter, Ramaswamy Sharma, Fedor Šimko, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 35
Targeting SARS-CoV-2 Non-Structural Proteins
W.G. Tam, Ana C. Lorenzo‐Leal, Luis R. Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13002-13002
Open Access | Times Cited: 20
Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells
Dalinda Eusébio, Milan Paul, Swati Biswas, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123959-123959
Open Access | Times Cited: 6
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 34
Rise of monkeypox: Lessons from COVID-19 pandemic to mitigate global health crises
Farah Ennab, Faisal A. Nawaz, Kapil Narain, et al.
Annals of Medicine and Surgery (2022) Vol. 79
Open Access | Times Cited: 26
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, et al.
International Journal of Surgery (2022) Vol. 98, pp. 106233-106233
Open Access | Times Cited: 23
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Russel J. Reıter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection
Joanna Schaenman, Hannah Byford, Tristan Grogan, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 19
Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis
Carolin Christina Drost, Alexandros Rovas, Irina Osiaevi, et al.
Angiogenesis (2024) Vol. 27, Iss. 3, pp. 411-422
Open Access | Times Cited: 4
Key insights into recent advances and challenges in COVID-19 management
Prakash Monika, Anushka A. Poola, Prithvi S. Prabhu, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Secondary osteonecrosis of the knee as a part of long COVID-19 syndrome: a case series
Sanjay R Agarwala, Mayank Vijayvargiya, Tushar Sawant
BMJ Case Reports (2022) Vol. 15, Iss. 3, pp. e248583-e248583
Open Access | Times Cited: 18
Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants
Jaber Dehghani, Ali Movafeghi, Elodie Mathieu‐Rivet, et al.
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 657-657
Open Access | Times Cited: 17
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History
Maciej Tarkowski, Wilco de Jager, Marco Schiuma, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
Dena Firouzabadi, Fatemeh Kheshti, Saeed Abdollahifard, et al.
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants
Tong Zhu, Sylvester Pawlak, Sima S. Toussi, et al.
Clinical Pharmacology in Drug Development (2022) Vol. 11, Iss. 12, pp. 1382-1393
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top